Jonathan Tobin
Director
Artios
United Kingdom
Biography
Jonathan is an Investment Manager at Arix Bioscience, specialising in biotechnology investments. Prior to recently joining Arix, Jonathan spent five years at Imperial Innovations, where he was a Principal in the Healthcare Ventures team. He was involved with the formation and investment in a number of early stage companies, including Inivata, Auspherix, Abingdon Health, Cell Medica, and Psioxus. Jonathan also worked at MRC Technology, sourcing and evaluating new small molecule and antibody drug discovery projects. He has a first class degree in biology from Oxford University, a PhD in Molecular Medicine from UCL and carried out postdoctoral research at the Cancer Research UK London Research Institute (now Crick Institute). Jonathan also has an MBA from Imperial College, and is a Trustee of the Autism Research Trust.
Research Interest
Dr. Jonathan having research interest in DNA analysis, Genetics, infectious disease , Molecular Biology, chemistry, of regenerative medicine and tissue engineering, Protein and Peptide Science, Psychology, Vaccine, biotechnology, internal medicine, Biochemistry
